Smartclaw
Payments companies reported to CMS as associated with Smartclaw. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Smartclaw, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Smartclaw
These are the largest totals companies reported as associated with Smartclaw. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Chris Jacob | Grand Rapids, MI | Cardiovascular Disease | $885.06 |
| Sandra Cole | Muskegon, MI | Vascular Surgery | $693.16 |
| Enrique Jimenez | Shreveport, LA | Interventional Cardiology | $285.98 |
| Kamalani Hanamaikai | Phoenix, AZ | Vascular & Interventional Radiology | $119.94 |
| Kenneth Serra | Eden Prairie, MN | Diagnostic Radiology | $119.94 |
| Joss Wertz | Chandler, AZ | Vascular & Interventional Radiology | $119.94 |
| Kiran Sekhar | Dayton, OH | Vascular & Interventional Radiology | $119.93 |
| Keith Jones | Carmichael, CA | Surgery | $55.51 |
| Aria Sasaki | Sacramento, CA | Vascular & Interventional Radiology | $54.31 |
| Henal Patel | Sacramento, CA | Vascular & Interventional Radiology | $54.30 |
Prescribed Smartclaw?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.